InVitria Launches Animal-Origin Free Transferrin

September 18, 2009

Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.

Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.

The new cell culture supplement, called Optiferrin, which supports cell growth by regulating the amount of iron transported to the cell. Because iron is required for healthy cell culture performance, it is a critical component to reach optimal performance.

Optiferrin addresses the need for animal-free transferrin in many applications including stem cells, primary cells, hybridoma cells, and Chinese hamster ovary cells.

According to the company’s press release, Optiferrin has undergone extensive testing by beta customers, who formulated Optiferrin into their cell culture media and liked the results.